[Letter: Acute myeloblastic leukemia: prevision of the efficiency by the combination of daunorubicin-cytosine-arabinoside].
D002478:Cells, Cultured; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000627:therapeutic use*; D004247:DNA / Q000096:biosynthesis; D003630:Daunorubicin; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D013936:Thymidine / Q000378:metabolism
D003561:Cytarabine; D004247:DNA; D013936:Thymidine; D003630:Daunorubicin
Leucémie alguë myéloblastique: prévision de l'efficacité du traitement par l'association daunorubinine-cytosine-arabinoside